Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genentech, Inc. (NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Stories about Genentech, Inc.
 
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Genentech Propped Up By Drug Pipeline (DNA)
January 18, 2008
Genentech released numbers that beat estimates, but the stock still dropped to some disappointing sales figures. Is this a cheap opportunity to pick up a strong company? Read More
from Investopedia Advisor Commentary
S&P Equity Research Downgrades Genentech (DNA) to Hold
January 15, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3266889 for the full story. Read More
from StreetInsider.com News Articles
David Moenning’s Daily State of the Markets: 01/15
January 15, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3265517 for the full story. Read More
from StreetInsider.com News Articles
Pre-Open Movers: MoneyGram (MGI) Sinks On Investment Losses, Manatron (MANA), Lifecore Biomedical (LCBM) Up on Buyouts
January 15, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3265249 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) NewsBite - Genentech Falls on Weak Drug Sales
January 15, 2008
Genentech Inc. (DNA) opened at 68.50. So far today, the stock has hit a low of 68.11 and a high of 69.62. DNA is now trading at 69.12, down 1.52 (-2.22%). The stock hit its 52 week high of 89.73 in... Read More
category DNA
from MarketIntelligenceCenter.com
After Hours Movers 11/14: Lenox Group (LNX) Up on Strategic Review; Hibbett Sports (HIBB), Coldwater Creek (CWTR) Lower on Guidance
January 14, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3263886 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) Reports Strong Q4 Earnings; Guides
January 14, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3263155 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) January straddle at $2.60 into EPS & Outlook
January 14, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3262869 for the full story. Read More
from StreetInsider.com News Articles
BWS Financial: Buy XOMA Ltd. (XOMA) Ahead of Genentech (DNA) Earnings
January 14, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3261979 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) NewsBite
January 08, 2008
Genentech ( NYSE: DNA ) closed yesterday at $66.27. So far the stock has hit a 52-week low of $65.35 and 52-week high of $89.73. Genentech stock has been showing support around 64.58 and resistance in... Read More
category DNA
from MarketIntelligenceCenter.com
WuXi PharmaTech Makes US Acquisition
January 03, 2008
WuXi PharmaTech will pay $151 million to acquire privately held AppTec Laboratory Services of St. Paul, Minn. Like WuXi, AppTec is involved in contract research outsourcing. But, while WuXi... Read More
from ChinaBio® Today
CV Therapeutics (CVTX) NewsBite - CV Therapeutics Falls with Biotechnology Sector
December 27, 2007
CV Therapeutics Inc. (CVTX) opened at 9.93. So far today, the stock has hit a low of 9.44 and a high of 10.02. CVTX is now trading at 9.60, down 0.36 (-3.63%). The stock hit its 52 week high of 14.67... Read More
category CVTX,CELG,DNA,GENZ
from MarketIntelligenceCenter.com
ViroPharma (VPHM) NewsBite - ViroPharma Tumbles with Biotechnology Sector
December 27, 2007
ViroPharma Inc. (VPHM) opened at 8.96. So far today, the stock has hit a low of 8.64 and a high of 9.02.VPHM is now trading at 8.65, down 0.35 (-3.85%). The stock hit its 52 week high of 18.39 in... Read More
category VPHM,DNA,GENZ,CELG
from MarketIntelligenceCenter.com
Altus Ends Partnership With Genentech
December 20, 2007
Analysts downgraded Altus Pharmaceuticals Inc. ( Nasdaq: ALTU ) after the company terminated its partnership with Genentech Inc. ( NYSE: DNA ) to develop and market its human growth hormone ALTU-238.... Read More
from MarketMinute.com Stock News
Mid-Day Report
December 20, 2007
The markets traded mixed during the midday as higher jobless claims tempered enthusiasm from upbeat earnings news with the Dow falling 47 points to 13,1604. Nasdaq gained 8 points to 2609. Read More
category Market News
from MarketMinute.com Market Updates
Altus Pharmaceuticals (ALTU) NewsBite - Altus Pharmaceuticals Ends Drug Collaboration with DNA
December 20, 2007
Altus Pharmaceuticals Inc. (ALTU) opened at 7.24. So far today, the stock has hit a low of 4.80 and a high of 7.31.ALTU is now trading at 5.29, down 4.59 (-63.40%). The stock hit its 52 week high of... Read More
category ALTU,DNA
from MarketIntelligenceCenter.com
Wachovia Downgrades Altus Pharmaceuticals (ALTU) to Market Perform
December 20, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3214799 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) NewsBite
December 10, 2007
Genentech ( NYSE: DNA ) ended the last trading session at $68.49. So far the stock has hit a 52-week low of $65.35 and 52-week high of $89.73. Genentech stock has been showing support around 65.68 and... Read More
category DNA
from MarketIntelligenceCenter.com
Comtex SmarTrend® Spotlights 12/6/2007
December 06, 2007
SmarTrend® DOWNTREND Alert: Genentech, Inc. ( NYSE:DNA ). Read More
from Comtex SmarTrend® News Briefs
Notable Analyst Rating Changes: CMCSA Up; DNA, GS, MS, WFC, TGT Down
December 06, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3179357 for the full story. Read More
from StreetInsider.com News Articles
Leerink Swann downgrades Genentech (DNA) to Market Perform
December 06, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3179277 for the full story. Read More
from StreetInsider.com News Articles
David Moenning's Daily State of the Markets: 12/06
December 06, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3179161 for the full story. Read More
from StreetInsider.com News Articles
Cowen Upgrades Genentech (DNA) to Outperform
December 06, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3178560 for the full story. Read More
from StreetInsider.com News Articles
Jefferies & Co Downgrades Genentech (DNA) to Hold
December 06, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3178425 for the full story. Read More
from StreetInsider.com News Articles
FDA Advises Against Expanding Use Of Genentech's Avastin
December 05, 2007
An FDA panel of advisors voted against expanding the use of Genentech Inc.'s ( NYSE: DNA ) colon and lung cancer treatment Avastin to breast cancer patients. The stock price plummeted $6.49 to close at... Read More
from MarketMinute.com Stock News
Closing Bell Report
December 05, 2007
Expansion in the service sector and an unexpected gain in factory orders sent the markets soaring to a sharply higher close with the Dow leaping 196 points to 13,445. Nasdaq jumped 47points to 2666. Read More
category Market News
from MarketMinute.com Market Updates
An FDA Panel Said Genentech (DNA) Avastin Should Not Be Approved for Breast Cancer
December 05, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3176427 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) Avastin shouldn't be approved, US panel says - Bloomberg.
December 05, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3176383 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) volatility Spikes to 43 on FDA's Oncologic Drug Advisory meeting
December 05, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3176358 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) NewsBite
December 03, 2007
Genentech ( NYSE: DNA ) ended the last trading session at $76.25. So far the stock has hit a 52-week low of $71.43 and 52-week high of $89.73. Genentech stock has been showing support around 75.28 and... Read More
category DNA
from MarketIntelligenceCenter.com
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here